TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.72
-0.01 (-0.17%)
Apr 28, 2025, 4:00 PM EDT - Market closed

TriSalus Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-30.05-59.36-47.19-28.85-31.83
Depreciation & Amortization
0.740.680.40.460.32
Other Amortization
0.61--1.745.97
Loss (Gain) From Sale of Assets
0.020.040.31-00.04
Stock-Based Compensation
5.441.40.370.110.02
Provision & Write-off of Bad Debts
0.19----
Other Operating Activities
-8.266.1211.53.979
Change in Accounts Receivable
-1.72-1.98-0.2-0.74-0.42
Change in Inventory
-1.5-1.07-0.18-0.730.76
Change in Accounts Payable
-4.382.845.253.18-0.03
Change in Other Net Operating Assets
-1.940.75-2.57-1.840.59
Operating Cash Flow
-40.84-50.58-32.31-22.7-15.58
Capital Expenditures
-0.35-0.59-0.66-1.1-0.55
Cash Acquisitions
--1-1-1-
Sale (Purchase) of Intangibles
---0.13-0.16-0.16
Other Investing Activities
-----9
Investing Cash Flow
-0.35-1.59-1.79-2.26-9.7
Long-Term Debt Issued
25--0.0525.48
Long-Term Debt Repaid
-0.08-0.09-0.13-1.35-0.7
Net Debt Issued (Repaid)
24.92-0.09-0.13-1.324.78
Issuance of Common Stock
15.610.180.090.050.01
Other Financing Activities
-2.5935.72---
Financing Cash Flow
37.9454.6313.4650.7724.81
Net Cash Flow
-3.252.46-20.6425.81-0.48
Free Cash Flow
-41.19-51.17-32.97-23.79-16.13
Free Cash Flow Margin
-139.95%-276.41%-265.91%-283.23%-296.74%
Free Cash Flow Per Share
-1.63-5.45-106.48-2.68-2.10
Cash Interest Paid
1.750.02-0.020.05
Cash Income Tax Paid
0.020.010.010-
Levered Free Cash Flow
-25.47-48.81-0.15-24.49-
Unlevered Free Cash Flow
-24.15-48.8-0.15-25.13-
Change in Net Working Capital
7.3818.94-22.649.43-
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q